期刊文献+

清热活血方对狼疮性肾炎热毒血瘀证患者血清PAF含量的影响 被引量:3

Effect of Qingre Huoxue Decoction on Serum PAF Level in Patients with Lupus Nephritis belonged to Noxious Heat Blood Stasis Syndrome
下载PDF
导出
摘要 目的观察清热活血方结合西药治疗对狼疮性肾炎(LN)热毒血瘀证患者血清血小板活化因子(PAF)含量的影响。方法将42例患者随机分为2组,对照组20例,治疗组22例。治疗组采用清热活血方加激素治疗;对照组仅单纯采用激素治疗,连续用药1个月。分别在治疗前及治疗后1个月测定患者血清PAF含量和统计各组SLEDAI积分。结果治疗组治疗后血清PAF含量及SLEDAI积分均明显低于对照组,差异具有显著性意义(P<0.05)。结论清热活血方治疗LN热毒血瘀证,可降低患者血清PAF含量,降低其疾病活动度,是一种较好的治疗方法。 Objective To investigate the effect of Qingre Huoxue decoction on serum PAF level in patients with lupus nephritis(LN) belonged to noxious heat blood stasis syndrome. Methods 42 cases of selected patients were randomly divided into two groups.The treatment group had 22 cases, and the control group had 20 cases. All patients were treated with conventional Western medicine such as glucocorticoid. The treatment group was additionally given Qingre Huoxue decoction for 1 month. Then the level of serum PAF and SLEDAI scores were observed respectively before and after the treatment in two groups. Results The level of serum PAF and SLEDAI scores had decreased obviously in the treatment group more than the control group, and the difference had significant significantce(P〈0.05). Conclusion Qingre Huoxue decoction could significantly reduce the level of serum PAF and SLEDAI scores in patients with LN belonged to noxious heat blood stasis syndrome, and is a kind of better therapy.
出处 《中国中医药现代远程教育》 2016年第13期58-59,共2页 Chinese Medicine Modern Distance Education of China
基金 花都区医疗卫生科研立项(No:14-HDWS-042)
关键词 清热活血方 狼疮性肾炎 热毒血瘀证 血小板活化因子 温毒发斑 Qingre Huoxue decoction lupus nephritis noxious heat blood stasis syndrome PAF spot induced by epidemic heat syndrome
  • 相关文献

参考文献10

二级参考文献23

  • 1阳晓,魏毅,叶任高,梁鸣,陈伟英,李幼姬,孔庆瑜,余学清.狼疮方对慢性GVHD狼疮样肾炎小鼠模型的作用[J].中国中西医结合杂志,2005,25(S1):74-77. 被引量:7
  • 2顾越英,叶霜.狼疮肾炎病理分型新进展的启示[J].中华风湿病学杂志,2004,8(9):513-514. 被引量:31
  • 3Jiang X, Chen F. The effect of lipid peroxides and superoxide dismutase on systemic lupus erythematosus: a preliminary study. Clin Immunol Immunopathol 1992, 63:39.
  • 4Ambrtsio G, Oriente A, Napoli C, et al. Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes plateletactivating factor. J Clin Invest 1994;93:2408.
  • 5Goldman R, Moshonov S, Zor U. Calcium-dependent PAF-stimulated generation of reactive oxygen species in a human keratinocyte cell line. Biochim Biophys Acta 1999;1438:349.
  • 6Clark WF, Parbtani A, Huff MW, et al. Flaxseed: a potential treatment for lupus nephritis. Kidney Int 1995;48:475.
  • 7Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992;35:630.
  • 8Schlondorff D,Neuwirth R.Platelet-activating factor and the kidney[J].Am J Physiol,1986,251:F1
  • 9Perico N,Delaini F,Tagliaferri M,et al.Effect of Plateletactivating factor and its specific receptor antagonist on glomerular permeability to proteins in isolated perfused rat kidney[J].Lab Invest,1988,58:163
  • 10Scherf H.Hemodynamic effects of platelet activating factor in the dog kidney invivo[J].Hypertension,1986,8(9):737-741

共引文献37

同被引文献62

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部